Atazanavir: In Pediatric Patients with HIV-1 Infection.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 2, p. 131, doi. 10.2165/11208550-000000000-00000
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2012 AND VI 14 AND IP 2
Results: 6
1
2
Safety and Tolerability of Loteprednol Etabonate 0.5% and Tobramycin 0.3% Ophthalmic Suspension in Pediatric Subjects.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 2, p. 119, doi. 10.2165/11596320-000000000-00000
- By:
- Publication type:
- Article
3
Cryopyrin-Associated Periodic Syndromes: Diagnosis and Management.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 2, p. 109, doi. 10.2165/11595040-000000000-00000
- By:
- Publication type:
- Article
4
Efficacy and Tolerability of Pharmacotherapies to Aid Smoking Cessation in Adolescents.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 2, p. 91, doi. 10.2165/11594370-000000000-00000
- By:
- Publication type:
- Article
5
Gastroesophageal Reflux Disease in Children and Adolescents: When and How to Treat.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 2, p. 79, doi. 10.2165/11594360-000000000-00000
- By:
- Publication type:
- Article
6
Medical Management of Nocturnal Enuresis.
- Published in:
- Pediatric Drugs, 2012, v. 14, n. 2, p. 71, doi. 10.2165/11594870-000000000-00000
- By:
- Publication type:
- Article